期刊文献+

生长抑素关节腔内注射治疗膝关节骨性关节炎的疗效观察 被引量:20

Clinical study on the treatment of knee osteoarthritis with somatostatin injected intra-articularly
下载PDF
导出
摘要 目的探讨生长抑素治疗膝关节骨性关节炎的疗效。方法对30例膝关节骨性关节炎患者进行关节腔内注射生长抑素750μg,每周1次,连续6周。记录治疗前后患者的VAS疼痛评分及治疗后发生的副作用,并采用林志雄评分标准评价治疗效果。结果治疗后患者疼痛明显减轻,关节综合评分优良率显著提高,没有发生严重副作用。结论生长抑素关节腔内注射治疗膝关节骨性关节炎疗效确切,副作用少,是治疗膝关节骨性关节炎的理想方法。 Objective To evaluate the therapeutic efficacy of somatostatin(SST) injected intra- articularly in the treatmere of knee osteoarthritis. Methods Twenty patients with knee osteoarthritis were treated with SST intra - articular injection. The treatment consisted of 6 injections administered weekly with 750 μg of SST. Visual analogue scales(VAS) before and after treatment as well as side effects were recorded, Ppatients were also evaluated by Linzhixiong's knee functional scales. Results The patients had improvements in pain and in Linzhixiong' s knee functional scales after intra- articular SST. There were no severn side effects happened. Condusion Intraarticular injection of SST satisfactorily benefits the patients with knee osteoarthritis without any severe side effect. It is an ideal treatment for knee osteoarthritis.
出处 《广东医学》 CAS CSCD 北大核心 2006年第1期8-9,共2页 Guangdong Medical Journal
关键词 生长抑素 膝关节 骨关节炎 关节内注射 Somatostatin Knee joint Osteoarthritis Intra- articular injection
  • 相关文献

参考文献7

  • 1林志雄,余楠生,卢伟杰.关节镜诊断和治疗膝关节骨关节炎[J].中华骨科杂志,1998,18(4):199-202. 被引量:343
  • 2张丽雯,卢振和,高崇荣.生长抑素治疗关节炎的临床研究[J].中国疼痛医学杂志,2001,7(1):39-41. 被引量:7
  • 3UTHMAN I, RAYNAJLD J P, HARAOUI B. Intra-articular therapy in osteoarthritis[J]. Postgrad Med J,2003,79(934) :449 - 53.
  • 4COARI G, DIFTANCO M, IAGNOCCO A, et al. Intra-articular somatostatin 14 reduces synovial thickness in rheumatoid arthritis: an ultrasonographic study[J]. hat J Clin Pharmacol Res, 1995,15 : 27 - 32.
  • 5SILVERI F,MOROSINI P,BRECCIAROLI D,et al.Intra-articular injection of somstostatin in knee osteoarthritis:clinical results and IGF - 1 serum levels[J].Int J Clin Pharmacol Res,1994,14(2) :79-85.
  • 6SILVERI F,BRECCIAROLI D,LO BARCO C.Somatostatin in peri-arthropathies of the shoulder:clinical effectiveness and tolerability after sub - acromial administration[J].Clin Ter,1997,148(3):75-81.
  • 7石韫珍,崔阳,崔锦芳.生长抑素关节腔内注射治疗类风湿性关节炎[J].实用医学杂志,2000,16(7):597-598. 被引量:5

二级参考文献18

  • 1娄思权,中华骨科杂志,1996年,16卷,56页
  • 2陆庄樵,中华骨科杂志,1990年,10期,281页
  • 3Matucci-cerinic M, Marabini S.Somatostatin treatment for pain in rheumatoid arthritis: a double blind versus placebostudy in knee involvement. Med Sci Res, 1988, 16: 233~234.
  • 4Fioravanti A, Govoni M, La Montagna G, et al. Somatostatin 14 and jointinflammation:evidence for intraarticular efficacy of prolonged administration in rhumatoidarthritis.Drugs Exptl Clin Res, 1995,97~103.
  • 5Matucci-Cerinic M. Sensory neuropeptides and rheumatic disease. Rheum Dis Clin NAm, 1993,19:975~976.
  • 6Silveri F, Morosini P, Brecciaroli D, et al. Intra-articular injection ofsomatostatin in knee osteoarthritis: clinical results and IGF-1serum levels. Int J ClinPharmacol Res,1994,14: 79~85.
  • 7Brodin GE, Olgart L, Panapoulos P. Evidence that substance P is a mediator ofantidromic vasodilation using somatostatin as a release inhibitor. Acta Physiol Scand,1984, 113: 155~157.
  • 8Kolasinski SL, Haines KA, Siegel EL, et al.Neuropeptides and inflammation: asornatostatin analog as selective antagonist of neutrophil activation by substance P.Arthritis Rheum, 1992,35: 369~372.
  • 9Payan DG, Hess CA, Goetzl EJ. Inhibition by somatostatin of the proliferation ofTlymphocytes and Molt-4 Lymphoblasts. Cell Im munol, 1984,84: 433~438.
  • 10Lembeck F, Holzer T. Substance P as neurogenic mediator of antidromicvosodilatation and neurogenic piasma extravasation. Naunyn Schmiedebergs Arch Pharmacol,1979, 310:175~177.

共引文献352

同被引文献140

引证文献20

二级引证文献135

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部